Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-07 11:23 am Purchase | 2026-06-09 | 13G | INTREXON CORP XON | Ares Trading SA | 17,467,152 4.900% | 17,467,152 (New Position) | Filing History |
| 2026-05-15 4:32 pm Sale | 2026-03-31 | 13G | PRECIGEN INC PGEN | Point72 Asset Management, L.P. | 6,741,861 1.900% | -11,641,381 (-63.33%) | Filing History |
| 2026-03-31 4:01 pm Sale | 2026-03-30 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 133,956,416 35.900% | -7,562,983 (-5.34%) | Filing History |
| 2026-02-13 10:56 am Sale | 2025-12-31 | 13G | PRECIGEN INC PGEN | Patient Capital Management LLC | 36,006,800 10.200% | -9,216,663 (-20.38%) | Filing History |
| 2026-01-23 4:05 pm Purchase | 2026-01-22 | 13G | PRECIGEN INC PGEN | Point72 Asset Management, L.P. | 18,383,242 5.200% | 18,383,242 (New Position) | Filing History |
| 2025-11-21 8:23 pm Sale | 2025-11-19 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 141,519,399 38.100% | -4,775,960 (-3.26%) | Filing History |
| 2025-10-30 12:49 pm Purchase | 2024-12-31 | 13G | PRECIGEN INC PGEN | Patient Capital Management LLC | 45,223,463 13.600% | 27,539,705 (+155.73%) | Filing History |
| 2025-09-23 4:06 pm Purchase | 2025-06-26 | 13G | PRECIGEN INC PGEN | William H. Miller III Living Trust dated April 17, 2017 | 34,051,925 9.200% | 34,051,925 (New Position) | Filing History |
| 2025-09-19 8:55 pm Purchase | 2025-09-17 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 146,295,359 39.400% | 29,451,002 (+25.21%) | Filing History |
| 2025-02-12 10:51 am Purchase | 2024-12-31 | 13G | PRECIGEN INC PGEN | Patient Capital Management LLC | 17,683,758 6.530% | 1,700,058 (+10.64%) | Filing History |
| 2024-12-30 7:29 pm Unchanged | 2024-12-30 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 116,844,357 39.800% | 0 (Unchanged) | Filing History |
| 2024-08-13 4:05 pm Purchase | 2024-08-09 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 116,844,357 40.500% | 23,529,411 (+25.22%) | Filing History |
| 2024-05-03 8:01 pm Sale | 2024-05-02 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 93,314,946 36.900% | -3,045,497 (-3.16%) | Filing History |
| 2024-02-27 1:48 pm Unchanged | 2023-12-29 | 13G | PRECIGEN INC PGEN | Patient Capital Management LLC | 15,983,700 6.420% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-29 | 13G | PRECIGEN INC PGEN | Patient Capital Management LLC | 15,983,700 6.420% | 15,983,700 (New Position) | Filing History |
| 2024-02-14 3:20 pm Unchanged | 2023-12-31 | 13G | INTREXON CORP XON | Ares Trading S.A. | 20,647,152 8.300% | 0 (Unchanged) | Filing History |
| 2023-01-31 4:01 pm Purchase | 2023-01-27 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 96,360,443 38.300% | 11,555,166 (+13.63%) | Filing History |
| 2023-01-27 09:29 am Unchanged | 2022-12-31 | 13G | INTREXON CORP XON | Ares Trading S.A. | 20,647,152 9.920% | 0 (Unchanged) | Filing History |
| 2022-10-07 4:42 pm Purchase | 2022-10-06 | 13D | INTREXON CORP XON | RANDAL J. KIRK | 84,805,277 40.700% | 2,983,114 (+3.65%) | Filing History |
| 2022-01-24 10:04 am Sale | 2021-12-31 | 13G | INTREXON CORP XON | Ares Trading S.A. | 20,647,152 9.990% | -6,751,367 (-24.64%) | Filing History |